TIDMEAH

ECO Animal Health Group plc

(AIM: EAH)

ECO RECEIVES CANADIAN MARKETING AUTHORISATION FOR AIVLOSIN® FOR SWINE RESPIRATORY DISEASE

ECO Animal Health Group plc is pleased to announce that its subsidiary ECO Animal Health Limited (ECO) has received a marketing authorisation for Aivlosin® in Canada from the Veterinary Drugs Directorate of Health Canada.

Aivlosin®, ECO's patented antimicrobial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in pigs and poultry.

This authorisation is for the use of Aivlosin® 625 mg/g water soluble granules for swine respiratory disease (SRD) associated with Haemophilus parasuis, Pasteurella multocida, and Streptococcus suis, three important bacterial respiratory pathogens of swine.

This new treatment meets all the guidelines for the responsible use of antimicrobials. Importantly, with global concerns about the use of antibiotics in food production animals, this treatment is under the control of veterinarians, is available under prescription only and has a low, highly effective therapeutic dose rate, short treatment duration and a zero day drug withholding period.

The product will be marketed through Pharmgate Animal Health Canada Inc. our well-established sales and marketing joint venture formed in 2010 with Pharmgate LLC, the majority-owned U.S. subsidiary of Jinhe Biotechnology Co. Ltd. in China.

Peter Lawrence, Chairman of ECO, commented "We are extremely pleased to receive this second marketing authorisation for the Aivlosin® water soluble granules formulation in Canada, the seventh largest pork producing country in the world. The swine respiratory disease segment is a key one and this latest approval demonstrates ECO's continued progress to becoming a major force in the international market for veterinary pharmaceutical products."

Contacts:

ECO Animal Health Group plc

 
Peter Lawrence                                 020 8336 6190 
Marc Loomes                                    020 8447 6906 
Spiro Financial 
Anthony Spiro                                  020 8336 6196 
Peel Hunt LLP (Nominated Adviser) 
Dan Webster, Adrian Trimmings, George Sellar   020 7418 8900 
N+1 Singer (Joint Broker)                      020 7496 3000 
Mark Taylor, Brough Ransom

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders

LEI: 2138009XN9DJ3YP70B55

Classification: 3.1. Additional regulated information required to be disclosed under the laws of a Member State

View source version on businesswire.com: http://www.businesswire.com/news/home/20171212005853/en/

 
This information is provided by Business Wire

(END) Dow Jones Newswires

December 13, 2017 02:00 ET (07:00 GMT)

Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Eco Animal Health Charts.
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Eco Animal Health Charts.